You can:
Name | 5-hydroxytryptamine receptor 5A |
---|---|
Species | Homo sapiens (Human) |
Gene | HTR5A |
Synonym | 5-HT5alpha 5-HT-5 MR22 Htr5 5-HT-5A [ Show all ] |
Disease | N/A |
Length | 357 |
Amino acid sequence | MDLPVNLTSFSLSTPSPLETNHSLGKDDLRPSSPLLSVFGVLILTLLGFLVAATFAWNLLVLATILRVRTFHRVPHNLVASMAVSDVLVAALVMPLSLVHELSGRRWQLGRRLCQLWIACDVLCCTASIWNVTAIALDRYWSITRHMEYTLRTRKCVSNVMIALTWALSAVISLAPLLFGWGETYSEGSEECQVSREPSYAVFSTVGAFYLPLCVVLFVYWKIYKAAKFRVGSRKTNSVSPISEAVEVKDSAKQPQMVFTVRHATVTFQPEGDTWREQKEQRAALMVGILIGVFVLCWIPFFLTELISPLCSCDIPAIWKSIFLWLGYSNSFFNPLIYTAFNKNYNSAFKNFFSRQH |
UniProt | P47898 |
Protein Data Bank | N/A |
GPCR-HGmod model | P47898 |
3D structure model | This predicted structure model is from GPCR-EXP P47898. |
BioLiP | N/A |
Therapeutic Target Database | N/A |
ChEMBL | CHEMBL3426 |
IUPHAR | 10 |
DrugBank | BE0004688 |
Name | Fluorocarazolol |
---|---|
Molecular formula | C18H21FN2O2 |
IUPAC name | 1-(9H-carbazol-4-yloxy)-3-(1-fluoropropan-2-ylamino)propan-2-ol |
Molecular weight | 316.376 |
Hydrogen bond acceptor | 4 |
Hydrogen bond donor | 3 |
XlogP | 3.6 |
Synonyms | S-1'[18F]FLUOROCARAZOLOL (S-(R*,S*))-1-(9H-Carbazol-4-yloxy)-3-((2-(fluoro-18F)-1-methylethyl)amino)-2-propanol BDBM85818 1-(9H-carbazol-4-yloxy)-3-(1-fluoropropan-2-ylamino)propan-2-ol L001139 [ Show all ] |
Inchi Key | QHLGXPUIUKSADT-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C18H21FN2O2/c1-12(9-19)20-10-13(22)11-23-17-8-4-7-16-18(17)14-5-2-3-6-15(14)21-16/h2-8,12-13,20-22H,9-11H2,1H3 |
PubChem CID | 133038 |
ChEMBL | N/A |
IUPHAR | N/A |
BindingDB | 85818 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Ki | <10000.0 nM | PMID11512051 | PDSP,BindingDB |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417